June 19th, 2019: PD Neurotechnology certified by DQS Med with the CE Certificate Class IIa for PDMonitor®.

PD Neurotechnology (PDN) has been certified by DQS Med with the CE Certificate Class IIa for its groundbreaking wearable medical device for continuous monitoring of patients with Parkinson's Disease, PDMonitor®. PDN has  implemented and maintains a quality assurance system which applies to the final controls of the product. Through an audit, documented in a report, performed by DQS Medizinprodukte GmbH, it was verified that the company's quality assurance system fulfills the requirements of Annex VI of Council Directive 93/42/EEC concerning medical devices with respect to PDMonitor®.

Prof Dimitris Fotiadis, R&D Director and Co-Founder of PDN, commented: “We are very proud to receive the CE marking certificate for PDMonitor®. It is a great milestone achieved, validating once again our vision and the team’s and company’s capabilities and performance”.

You can find the press release here.